Msmagazine iconMsmagazineSep 10, 2026 ~1 min source read

Fifth Circuit Judges Seem Skeptical of Louisiana’s Challenge to Telehealth Abortion

9, a three-judge panel of the 5th Circuit Court of Appeals in New Orleans heard oral arguments in Louisiana v. FDA, a lawsuit filed by the Louisiana attorney general seeking to end telehealth abortion nationwide, even in states that protect abortion access.

Fifth Circuit Judges Seem Skeptical of Louisiana’s Challenge to Telehealth Abortion

Share this story

Send the public story page.

Useful takeaways from this story.

9, a three-judge panel of the 5th Circuit Court of Appeals in New Orleans heard oral arguments in Louisiana v.

FDA, a lawsuit filed by the Louisiana attorney general seeking to end telehealth abortion nationwide, even in states that protect abortion access.

Since the fall of Roe and a national snapback of abortion rights in a majority of U.S.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

9, a three-judge panel of the 5th Circuit Court of Appeals in New Orleans heard oral arguments in Louisiana v. FDA, a lawsuit filed by the Louisiana attorney general seeking to end telehealth abortion nationwide, even in states that protect abortion access. Since the fall of Roe and a national snapback of abortion rights in a majority of U.S.

How it works

  • states, the antiabortion movement has been laser focused on trying to restrict telehealth abortion because it's increasing in both awareness and popularity, and it allows patients to circumvent state bans.
  • The 5th Circuit is considered one of the most conservative appeals courts in the country.
  • The three-judge panel randomly selected to hear Wednesday's case included two judges appointed by Democratic presidents:
  • During oral arguments, all three judges indicated skepticism about Louisiana's arguments, starting with Louisiana's right to bring the case.
  • While the recent 5th Circuit hearing offers hope that efforts to restrict mifepristone through the courts will not succeed anytime soon, two greater threats remain:

What to take from it

Trump's antiabortion nominee to lead the FDA, Heidi Overton, and Attorney General Todd Blanche's promise to restrict the mailing of mifepristone under the Comstock Act. (This move would spur immediate lawsuits by Democratic states and manufacturers of mifepristone.) Meanwhile, abortion rights advocates will never give up in finding new ways to put abortion pills in women's hands.

Details worth keeping

The third judge, Judy Richman, was appointed by George W.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app